28/07/2026
Noctiluca's AGM update reinforces our view that the company is making good progress towards industrial qualification and commercialisation. Management provided greater clarity on the remaining milestones and timeline for its lead programme, supporting our expectation of a meaningful growth inflection from FY28. Meanwhile, NCEIL continues to gain validation across a broader range of partners and applications. Technology risks have reduced materially, we maintain our central valuation of PLN183/share with further commercialisation milestones the key catalyst for upside.
29/06/2026
Noctiluca is a dynamic Polish advanced materials company rapidly making the transition from an R&D-led business to an emerging industrial supplier. Listed on the Warsaw Stock Exchange under the ticker NCL, the company develops specialist materials for OLED displays, with a particular focus on solving one of the industry’s toughest challenges: improving the efficiency and lifetime of blue OLED pixels. Noctiluca is now working with eight of the world’s 10 largest display manufacturers, while its lead programme with the world’s largest telecommunications equipment vendor is progressing rapidly towards industrial qualification and mass production – a stage that no European OLED materials company has previously reached. We highlight five reasons why Noctiluca represents an interesting investment case. NCEIL, Noctiluca’s next-generation electron-injection-layer material, is driving a rapid acceleration in commercial engagement. The addressable market is large and growing. Noctiluca is approaching a pivotal industrialisation milestone. Noctiluca remains on track for a significant growth inflection from FY27. Our analysis points to significant valuation upside. For more analysis on Noctiluca, please see our latest research.
12/06/2026
Noctiluca’s technical qualification programme with its lead telecommunications OEM partner is now estimated to be c 90% complete. Progression through the remaining qualification milestones should lead to production-line testing and industrial qualification – the final stage before potential commercial scale-up. Successful completion would materially strengthen the pathway to industrial-scale deployment and support our expectation of a revenue inflection from FY27.